EGFR and colorectal cancer: KEGG pathway enrichment analysis identified 141 significantly associated pathways (p < 0.05), including VEGF signaling, EGFR tyrosine kinase inhibitor resistance, estrogen signaling, PI3K–Akt signaling, and pathways related to colorectal cancer (Figure 4D).